适用于葡萄 (Vitis vinifera L.) 果大小的GA3的监管机制
Wen-Fang Li1, Qi Zhou2, Zong-Huan Ma1
1College of Horticulture, Gansu Agricultural University, Lanzhou, 730070, PR China.
Plant physiology and biochemistry : PPB
|March 30, 2024
概括
吉伯雷林A3 (GA3) 通过增强细胞扩张和改变激素水平,显著增加了葡萄的大小. 非编码RNA被确定为GA3介导的水果发育过程中的关键调节者.
科学领域:
- 植物生物学 植物生物学
- 分子生物学分子生物学
- 农业科学 农业科学
背景情况:
- 吉伯雷林A3 (GA3) 是一种关键的植物激素,调节生长和发育.
- 了解GA3在果实发育中的作用,特别是葡萄树中的作用,对于农业应用至关重要.
- 非编码RNAs (ncRNAs) 在GA3介导的果实大小调节中的参与仍然在很大程度上未被探索.
研究的目的:
- 为了研究GA3对"红球"葡萄果的发育的影响.
- 确定分子机制,包括激素信号传递和ncRNA调节,是GA3诱导的果实大小增加的基础.
- 探索特定基因和ncRNAs在控制葡萄大小方面的潜在作用.
主要方法:
- 在初始扩张阶段将Tween-20配方的GA3应用于葡萄集群.
- 分析水果的物理参数 (细胞长度,大小,直径,体积).
- 植物激素水平的量化 (IAA,ZT,ABA).
- RNA测序用于识别差异表达的mRNA,lncRNA和miRNA.
- 在番茄中对VvRAX2的基因表达分析和功能验证.
主要成果:
- GA3的应用显著增加了葡萄果细胞的大小,直径和体积.
- GA3改变了内源性激素水平,增加了辅酶 (IAA) 和血 (ZT),同时降低了ABA.
- 不同表达分析揭示了mRNA,lncRNA和miRNA配置文件的变化,涉及激素通路和特定基因 (GID2,SAUR,ACS).
- 预测特定的miRNAs可以调节参与水果发育的关键基因.
- 在番茄中证实了GA3对VvRAX2的上调及其在增加果实大小中的作用.
结论:
- GA3有效地促进葡萄果的发育和大小的增加.
- GA3诱导的果实扩大涉及复杂的荷尔蒙交叉和差异性基因表达.
- 非编码RNAs,特别是miRNAs,通过调节关键发育基因,在调节GA3对葡萄大小的影响方面发挥着重要作用.
- VvRAX2是水果大小的潜在积极调节者,为未来的育种策略提供了目标.
更多相关视频
13:02The Terroir Concept Interpreted through Grape Berry Metabolomics and Transcriptomics
Published on: October 5, 2016
10.4K
10:40Comprehensive Workflow for the Genome-wide Identification and Expression Meta-analysis of the ATL E3 Ubiquitin Ligase Gene Family in Grapevine
Published on: December 22, 2017
10.5K
相关概念视频
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Drug Control Governance: Regulatory Bodies and Their Impact
706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
